Clinical trials: completed, sponsored by Bayer
Contraception
LCS12 vs. ENG Subdermal Implant (Nexplanon) Discontinuation Rate Study
The primary objective is to demonstrate that discontinuation rates in women (ages 18-35 years inclusive) using LCS12 are not higher than those seen in women using ENG subdermal implant over a period of 12 months.
- Trial name
- NCT01397097
- Testing
- LNG-IUS (BAY 86-5028), 68 mg etonorgestrel implant for subdermal use (Nexplanon)
- Where
- 43 sites in Australia, Finland and 4 more
- Volunteers
- 766 people
- Sponsor
- Bayer
Hematology
Naproxen Sodium/ASA Platelet Study
To determine if administration of naproxen sodium 220 mg maintains the platelet inhibitory effect of a low dose Immediate Release Aspirin (IR ASA) regimen.
- Trial name
- Kontakt (NCT02229461)
- Testing
- Naproxen Sodium (Aleve, BAY117031), Acetylsalicylic Acid (Aspirin, BAYE4465)
- Where
- United States
- Volunteers
- 117 people, healthy volunteers welcome
- Sponsor
- Bayer
Neoplasms
Roniciclib Mass Balance Study
The purpose of this trial is to investigate the fate of the roniciclib (study drug) in the body in a so called mass-balance study.
- Trial name
- NCT02390154
- Testing
- roniciclib (BAY 1000394)
- Where
- Hungary
- Volunteers
- 7 people
- Sponsor
- Bayer
Sunscreening Agents
18348-Human Phototoxicity Test
To determine the phototoxic potential of a topically applied article in human subjects
- Trial name
- NCT02823483
- Testing
- Sunscreen Lotion (BAY987521), Untreated Skin
- Where
- United States
- Volunteers
- 35 people, healthy volunteers welcome
- Sponsor
- Bayer
Sunscreening Agents
18349-Human Photoallergy Test
To evaluate the potential of a test material to produce a photoallergic response.
- Trial name
- NCT02823496
- Testing
- Sunscreen Lotion , BAY 987521, Untreated skin
- Where
- United States
- Volunteers
- 60 people, healthy volunteers welcome
- Sponsor
- Bayer
Sunscreening Agents
Human Phototoxicity Test
To determine the phototoxic potential of a topically applied article in human subjects
- Trial name
- NCT02751489
- Testing
- Bain De Soliel - Solid
- Where
- United States
- Volunteers
- 35 people, healthy volunteers welcome
- Sponsor
- Bayer
Medical Oncology
Roniciclib (BAY 1000394) Drug-Drug Interaction (DDI) Study
To evaluate the effect of itraconazole, a strong CYP3A4 inhibitor, on the pharmacokinetics of roniciclib in cancer patients. To assess safety and tolerability of roniciclib dosing when administered with and without itraconazole…
- Trial name
- NCT02457351
- Testing
- Roniciclib (BAY 1000394), Itraconazole (Sporanox)
- Where
- 4 sites in Canada
- Volunteers
- 14 people
- Sponsor
- Bayer
Endometriosis
Ascending Dose Study to Investigate the Safety, Tolerability and Pharmacokinetics of BAY1128688 After Multiple Oral Administrations in Healthy Women
The objective of this trial is to investigate the safety and tolerability of BAY1128688 and to determine the concentration of this substance in blood after repeated administration by the oral route.
- Trial name
- NCT02434640
- Testing
- BAY1128688
- Where
- 3 sites in Germany
- Volunteers
- 51 people, healthy volunteers welcome
- Sponsor
- Bayer
Macular Edema
Efficacy and Safety of VEGF Trap Eye in Diabetic Macular Edema (DME) With Central Involvement
To determine the efficacy of intravitreally (IVT) administered VEGF Trap-Eye on the best-corrected visual acuity (BCVA) assessed by the early treatment diabetic retinopathy study (ETDRS) chart in subjects with diabetic macular…
- Trial name
- VIVID EAST (NCT01783886)
- Testing
- Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321), Macular Laser Photocoagulation
- Where
- 25 sites in China, Hong Kong and 2 more
- Volunteers
- 381 people
- Sponsor
- Bayer
Endometriosis
Study to Investigate the Efficacy of a Non-hormonal Drug Against Endometriosis Associated Pelvic Pain
This study was designed as a proof-of-concept trial to evaluate safety, tolerability, and the efficacy of 1800 mg (ZK 811752 600 mg given orally three times daily) over 12 weeks for the treatment of endometriosis associated…
- Trial name
- NCT00185341
- Testing
- CCR1-Antagonist (BAY86-5047, ZK811752)
- Where
- 32 sites in Czechia, Denmark and 5 more
- Volunteers
- 110 people
- Sponsor
- Bayer
Kidney Diseases
Dose Escalation Study to Investigate Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of BAY85-3934 in Subjects With Chronic Kidney Disease (CKD)
Primary objective was to assess in subjects with CKD: Safety and tolerability of molidustat (BAY 85-3934), effects of molidustat on non-invasive hemodynamics Secondary objectives were to assess: Effects on pharmacodynamic…
- Trial name
- NCT01679587
- Testing
- Molidustat (BAY85-3934)
- Where
- 3 sites in Germany
- Volunteers
- 49 people
- Sponsor
- Bayer
Contraception
Study of Treatment With the Combination of Drospirenone Plus Ethinyl Estradiol Plus Levomefolate Calcium in Mexican Women Seeking Contraception
The objective of this study is to compare the red blood cell (RBC) and plasma concentrations of folate in subjects treated with drospirenone (DRSP)/ethinyl estradiol (EE) plus levomefolate calcium (L-5-MTHF) at 24 weeks with…
- Trial name
- NCT01902264
- Testing
- EE20/DRSP/L-5-MTHF (Beyaz, BAY98-7071)
- Where
- Mexico
- Volunteers
- 34 people, healthy volunteers welcome
- Sponsor
- Bayer
Wound Healing
Pilot Study to Assess Number of Patients for Main Trial
The objective of the study was to investigate the efficacy of Bepanthen® wound healing ointment compared to placebo in a superficial abrasive wound model. The primary objective was the re-epithelization at Day 5.
- Trial name
- NCT02734628
- Testing
- Dexpanthenol (Bepanthen® Wund- und Heilsalbe, BAY81-2996)
- Where
- Germany
- Volunteers
- 28 people, healthy volunteers welcome
- Sponsor
- Bayer
Carcinoma
Study to Determine the Safety, Maximum Tolerated Dose, Pharmacokinetics of Sorafenib (BAY43-9006)
The primary objective of the study was to define the safety profile and maximum tolerated dose (MTD) of sorafenib tablets in combination with carboplatin and paclitaxel chemotherapy in patients with advanced, refractory solid…
- Trial name
- NCT00941863
- Testing
- Sorafenib 100 mg (50-mg tablet), Sorafenib 200 mg (50-mg tablet), Sorafenib 400 mg (50-mg tablet)
- Where
- 3 sites in United States
- Volunteers
- 158 people
- Sponsor
- Bayer
Clinical Trial, Phase I
Study in Healthy Young Women to Investigate the Pharmacodynamics, Pharmacokinetics and Safety of Vilaprisan
This is a study in healthy women of reproductive age to investigate the pharmacodynamics (mainly ovarian activity), pharmacokinetics and safety of vilaprisan after daily oral administration of 4 different doses over 84 days…
- Trial name
- NCT02262663
- Testing
- Vilaprisan (BAY1002670)
- Where
- 2 sites in Germany
- Volunteers
- 70 people, healthy volunteers welcome
- Sponsor
- Bayer
Constipation
Dose-Finding Trial of Polyethylene Glycol 3350 Laxative Plus Electrolytes for the Treatment of Constipation (Protocol P07515)
The primary objective of the study was to evaluate the proportion of subjects with a bowel movement (BM) without straining or without hard and/or lumpy stool within the first 24 h of treatment for subjects taking 1 of 3 single…
- Trial name
- NCT01212445
- Testing
- PEG 3350 laxative plus electrolytes (PEG + E)/Macrogol (Movicol®, BAY81-8430)
- Where
- Ireland
- Volunteers
- 154 people
- Sponsor
- Bayer
Hyperphosphatemia
Open Study of BAY77-1931 (Lanthanum Carbonate) in Continuous Ambulatory Peritoneal Dialysis Patients
The purpose of this study is to assess the effect on reduction of serum phosphate and the safety of BAY77-1931 (lanthanum carbonate) in patients with hyperphosphatemia undergoing continuous ambulatory peritoneal dialysis.
- Trial name
- NCT01518387
- Testing
- Lanthanum Carbonate (BAY77-1931)
- Where
- 11 sites in Japan
- Volunteers
- 43 people
- Sponsor
- Bayer
Clinical Trial, Phase I
Study in Postmenopausal Women to Investigate the Drug-drug Interaction (DDI) Between Itraconazole(ITZ) and Orally Administered Vilaprisan; Absolute Bioavailability Using Intravenous Microtracer Dose of [14C]Vilaprisan
This is a study in postmenopausal women to investigate the Drug-drug interaction (DDI) between itraconazole(ITZ) and orally administered vilaprisan; absolute bioavailability using intravenous microtracer dose of [14C]vilaprisan.
- Trial name
- NCT02456129
- Testing
- Vilaprisan (BAY1002670), [14C] Vilaprisan, Itraconazole(ITZ)
- Where
- United Kingdom
- Volunteers
- 14 people, healthy volunteers welcome
- Sponsor
- Bayer
Hypertension, Pulmonary
Epidemiology and Treatment Patterns of Paediatric PAH (Pulmonary Arterial Hypertension)
To describe the prevalence, incidence and current treatment and procedures patterns in a US pediatric population with PAH in MarketScan database during the period 2010-2013
- Trial name
- NCT02576002
- Testing
- Assigned pulmonary hypertension medication
- Where
- United States
- Volunteers
- 2,691 people
- Sponsor
- Bayer
Healthy Volunteers
Relative Bioavailability Study
To investigate relative bioavailability of crushed tablets suspended in apple sauce or water
- Trial name
- NCT02159313
- Testing
- Riociguat(Adempas,BAY63-2521)
- Where
- Germany
- Volunteers
- 48 people, healthy volunteers welcome
- Sponsor
- Bayer
The first 1,020 results can be paged through. Add a filter or change the sort order to reach the rest.